DIRAS3 and neoplasm: In addition to providing a foundation for future experiments to determine the mechanism of ARHI-mediated metabolic perturbation, these results suggest that targeted inhibition of metabolic pathways such as glutaminolysis, may be a powerful approach to overcoming ARHI-mediated tumor dormancy.